JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quinn, C. P.
Right arrow Articles by Leppla, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quinn, C. P.
Right arrow Articles by Leppla, S. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 30, 20124-20130, Oct, 1991

Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis

CP Quinn, Y Singh, KR Klimpel and SH Leppla
Laboratory of Microbial Ecology, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.

Linker insertion mutagenesis was employed to create structural disruptions of the lethal factor (LF) protein of anthrax toxin to map functional domains. A dodecameric linker was inserted at 17 blunt end restriction enzyme sites throughout the gene. Paired MluI restriction sites within the linker allowed the inserts to be reduced from four to two amino acids. Shuttle vectors containing the mutated genes were transformed into the avirulent Bacillus anthracis UM23C1-1 for expression and secretion of the gene products. Mutations at five sites in the central one-third of the sequence made the protein unstable, and purified protein could not be obtained. Mutated LF proteins with insertions at the other sites were purified and assessed for toxic activity in a macrophage lysis assay and for their ability to bind to the protective antigen (PA) component of anthrax toxin, the receptor binding moiety. Most insertions located in the NH2-terminal one-third of the LF protein eliminated both toxicity and binding to PA, while all four insertions in the COOH-terminal one-third of the protein eliminated toxicity without affecting binding to PA. These data support the hypothesis that the NH2-terminal domain contains the structures required for binding to PA and the COOH-terminal domain contains the putative catalytic domain of LF.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
G. C. Kedar, V. Brown-Driver, D. R. Reyes, M. T. Hilgers, M. A. Stidham, K. J. Shaw, J. Finn, and R. J. Haselbeck
Evaluation of the metS and murB Loci for Antibiotic Discovery Using Targeted Antisense RNA Expression Analysis in Bacillus anthracis
Antimicrob. Agents Chemother., May 1, 2007; 51(5): 1708 - 1718.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Melnyk, K. M. Hewitt, D. B. Lacy, H. C. Lin, C. R. Gessner, S. Li, V. L. Woods Jr., and R. J. Collier
Structural Determinants for the Binding of Anthrax Lethal Factor to Oligomeric Protective Antigen
J. Biol. Chem., January 20, 2006; 281(3): 1630 - 1635.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Halverson, R. G. Panchal, T. L. Nguyen, R. Gussio, S. F. Little, M. Misakian, S. Bavari, and J. J. Kasianowicz
Anthrax Biosensor, Protective Antigen Ion Channel Asymmetric Blockade
J. Biol. Chem., October 7, 2005; 280(40): 34056 - 34062.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
N.-K. Lim, J.-H. Kim, M. S. Oh, S. Lee, S.-Y. Kim, K.-S. Kim, H.-j. Kang, H. J. Hong, and K.-S. Inn
An Anthrax Lethal Factor-Neutralizing Monoclonal Antibody Protects Rats before and after Challenge with Anthrax Toxin
Infect. Immun., October 1, 2005; 73(10): 6547 - 6551.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liang, J. J. Young, S. A. Boone, D. S. Waugh, and N. S. Duesbery
Involvement of Domain II in Toxicity of Anthrax Lethal Factor
J. Biol. Chem., December 10, 2004; 279(50): 52473 - 52478.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
H. Barth, K. Aktories, M. R. Popoff, and B. G. Stiles
Binary Bacterial Toxins: Biochemistry, Biology, and Applications of Common Clostridium and Bacillus Proteins
Microbiol. Mol. Biol. Rev., September 1, 2004; 68(3): 373 - 402.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Liu, S. Netzel-Arnett, H. Birkedal-Hansen, and S. H. Leppla
Tumor Cell-selective Cytotoxicity of Matrix Metalloproteinase-activated Anthrax Toxin
Cancer Res., November 1, 2000; 60(21): 6061 - 6067.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
F. Brossier, M. Weber-Levy, M. Mock, and J.-C. Sirard
Protective Antigen-Mediated Antibody Response against a Heterologous Protein Produced In Vivo by Bacillus anthracis
Infect. Immun., October 1, 2000; 68(10): 5731 - 5734.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Cohen, I. Mendelson, Z. Altboum, D. Kobiler, E. Elhanany, T. Bino, M. Leitner, I. Inbar, H. Rosenberg, Y. Gozes, et al.
Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax
Infect. Immun., August 1, 2000; 68(8): 4549 - 4558.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. Singh, K. R. Klimpel, S. Goel, P. K. Swain, and S. H. Leppla
Oligomerization of Anthrax Toxin Protective Antigen and Binding of Lethal Factor during Endocytic Uptake into Mammalian Cells
Infect. Immun., April 1, 1999; 67(4): 1853 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Varughese, A. V. Teixeira, S. Liu, and S. H. Leppla
Identification of a Receptor-Binding Region within Domain 4 of the Protective Antigen Component of Anthrax Toxin
Infect. Immun., April 1, 1999; 67(4): 1860 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
J. P. Barnard and A. M. Friedlander
Vaccination against Anthrax with Attenuated Recombinant Strains of Bacillus anthracis That Produce Protective Antigen
Infect. Immun., February 1, 1999; 67(2): 562 - 567.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. E. Hammond and P. C. Hanna
Lethal Factor Active-Site Mutations Affect Catalytic Activity In Vitro
Infect. Immun., May 1, 1998; 66(5): 2374 - 2378.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Gupta, S. Batra, A. P. Chopra, Y. Singh, and R. Bhatnagar
Expression and Purification of the Recombinant Lethal Factor of Bacillus anthracis
Infect. Immun., February 1, 1998; 66(2): 862 - 865.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhao, J. C. Milne, and R. J. Collier
Effect of Anthrax Toxin's Lethal Factor on Ion Channels Formed by the Protective Antigen
J. Biol. Chem., August 4, 1995; 270(31): 18626 - 18630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Singh, H. Khanna, A. P. Chopra, and V. Mehra
A Dominant Negative Mutant of Bacillus anthracis Protective Antigen Inhibits Anthrax Toxin Action in Vivo
J. Biol. Chem., June 15, 2001; 276(25): 22090 - 22094.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. B. Lacy, M. Mourez, A. Fouassier, and R. J. Collier
Mapping the Anthrax Protective Antigen Binding Site on the Lethal and Edema Factors
J. Biol. Chem., January 18, 2002; 277(4): 3006 - 3010.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.